0001104659-22-034156.txt : 20220316
0001104659-22-034156.hdr.sgml : 20220316
20220316060418
ACCESSION NUMBER: 0001104659-22-034156
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220314
FILED AS OF DATE: 20220316
DATE AS OF CHANGE: 20220316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brady James Aloysius
CENTRAL INDEX KEY: 0001916987
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38067
FILM NUMBER: 22743217
MAIL ADDRESS:
STREET 1: C/O VERONA PHARMA PLC
STREET 2: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verona Pharma plc
CENTRAL INDEX KEY: 0001657312
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
BUSINESS PHONE: 011-44-0-2032834200
MAIL ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
4
1
tm229323-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-03-14
0
0001657312
Verona Pharma plc
VRNA
0001916987
Brady James Aloysius
3 MORE LONDON RIVERSIDE
LONDON
X0
SE1 2RE
UNITED KINGDOM
1
0
0
0
Share Options (Right to Buy)
0.6025
2022-03-14
4
A
0
288000
0
A
2032-03-13
Ordinary Shares
288000
288000
D
The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
The option vests and becomes exercisable as to 25% on August 1, 2022, 25% on November 1, 2022, 25% on February 1, 2023 and 25% on May 1, 2023.
/s/ Claire Poll, Attorney-in-fact for James Aloysius Brady
2022-03-16